New drug aims to slow type 1 diabetes in early stages
Disease control
Recruiting now
This study tests a new drug called SAB-142 in people recently diagnosed with type 1 diabetes. The goal is to see if it can help the body keep making its own insulin longer, which may slow the disease. About 159 people aged 5 to 40 will take either the drug or a placebo, and resea…
Phase: PHASE2 • Sponsor: SAb Biotherapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC